1 / 10

Nuclear Medicine Therapeutics Market Growth Drivers 2022-2029

The cardiology segment is expected to hold a major market share over the forecast period by application. The major factors attributing to the growth of this segment include the rise in the prevalence of cardiovascular disorders and the surge in applications of SPECT in diagnosing cardiac issues. Cardiovascular disorders include coronary artery disease (CAD), strokes, and atrial fibrillation, necessitating an efficient diagnosis through SPECT.

Prathibha3
Télécharger la présentation

Nuclear Medicine Therapeutics Market Growth Drivers 2022-2029

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Nuclear Medicine Therapeutics Market|2022-2029 Nuclear Medicine Radioisotopes Market is Segmented By Type of Radioisotopes (Fluorine-18, Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Rubidium-82 (Rb-82), Iodine-131 (I-131), Lutetium-177 (Lu-177), Radium-223 (Ra- 223) and Alpharadin, Actinium-225 (Ac-225), By Application (Cardiology, Oncology, Thyroid, Neurology, Other), By End-User (Hospitals, Diagnostic centers, Specialty Clinics, Education and Research institutes, Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029. Copy Right: DataM Intelligence 4Market Research info@datamintelligence.com

  2. Nuclear Medicine Therapeutics Market| 2022-2029 Overview: Nuclear medicine is a branch of medicine that employs a small amount of radiology or other radioactive elements to examine the structure or function of an organ in the human body. It is mostly utilized for many sorts of disorders that require nuclear medicine diagnosis and treatment. Radiopharmaceuticals are used to treat the patient. This form of treatment is required for a variety of conditions, including thyroid cancer, various types of bone discomfort, and hyperthyroidism. Nuclear medicine therapies employing radioactive sources include thyroid therapy, pain relief from bone metastases, and treatment of some other tumours. New radiopharmaceuticals are being developed to treat various cancers. The worldwide burden of cancer and heart disorders has recently grown due to rising rates of these diseases. This has aided in raising public knowledge of nuclear medical treatment. As a result, all of these factors have contributed to the market's expansion. Browse for Full Report @ https://www.datamintelligence.com/research-report/nuclear-medicine-radioisotopes- market Copy Right: DataM Intelligence 4Market Research info@datamintelligence.com

  3. Nuclear Medicine Therapeutics Market|2022-2029 Market Size and Future Apprehension: According to the most recent DataM Intelligence analysis, the worldwide Nuclear Medicine Therapeutics market was valued at USD 9.49 billion in 2021 and is expected to reach USD 25.7 billion by 2030, growing at a CAGR of 11.7% between 2023 and 2030. Market Dynamics: Drivers: With a growth in the global elderly population in both emerging and established nations, the number of cardiovascular illnesses has increased. The rising prevalence of cardiovascular disease in the senior population has produced a high demand for nuclear medicine. There has also been an increase in the number of cancer patients worldwide, which is a serious sickness that necessitates the use of nuclear medications. This sort of therapy is extremely significant in the detection and treatment of cancer. . During the forecast period, the number of cancer patients and deaths will increase to 23.3 million. Nuclear medicine plays a significant part in cancer treatment by identifying cancers as well as treating these tumours or cell proliferation. The market is likely to rise over the forecast period due to an increase in the frequency of these types of disorders. Copy Right: DataM Intelligence 4Market Research info@datamintelligence.com

  4. Nuclear Medicine Therapeutics Market|2022-2029 Restraints: Radioisotopes, on the other hand, have a short half-life, resulting in quicker degradation. Furthermore, the cost of equipment and radioisotopes is too expensive. As a result, many health-care providers are unwilling to invest in these medicines. As a result, market expansion has been restrained Key Markets Developments: ✓ Noria Therapeutics will be bought by Bayer in 2021 in order to provide a broader cancer portfolio for nuclear medicine. These businesses produce radiopharmaceuticals, which are utilised in illness diagnosis and therapy. ✓ In the year 2021, a deal was signed between Northstar medical radioisotopes, which manufactures radiopharmaceuticals, and GE Healthcare to offer iodine 123 capsules for distribution in the United States. Browse For Our Sample Request @ https://www.datamintelligence.com/download-sample/nuclear-medicine- radioisotopes-market Copy Right: DataM Intelligence 4Market Research info@datamintelligence.com

  5. Nuclear Medicine Therapeutics Market|2022-2029 Regional Insights: Geographically, the nuclear medicine market segment will have the greatest market share in North America. Because of the existence of many manufacturing units in this region, this market is likely to have a prominent position. The availability of the best healthcare infrastructure in this area, together with the acceptance of treatments involving the use of nuclear medicine, will drive market expansion in the North American region. Covid-19 Impact Analysis: The nuclear medicine business, like all other markets, was severely impacted by the epidemic. The advent of the COVID-19 pandemic in 2019 caused a protracted period of global halt. Many adjustments were made to the running of various institutions and research centers in order to preserve social distance. Different sorts of medical facilities were barred from performing any study in order to prevent the sickness from spreading further. Copy Right: DataM Intelligence 4Market Research info@datamintelligence.com

  6. Nuclear Medicine Therapeutics Market|2022-2029 Agriculture Automation and Control Agriculture Automation and Control SystemsMarket SystemsMarket Segmentation Analysis: The segments covers in this report By Application: By type: • • • Oncology Cardiology Thyroid • • Alpha Emitters Beta Emitters • Brachytherapy • others Copy Right: DataM Intelligence 4Market Research info@datamintelligence.com

  7. Nuclear Medicine Therapeutics Market|2022-2029 Major Countries Focused: Major Countries Focused: Geographical Classification Geographical Classification • • • • • North America Europe South America Asia Pacific Middle East and Africa • • • • • • • • • • • United States Canada Brazil Spain Italy United Kingdom South Korea Russia China Japan Rest of the Countries Copy Right: DataM Intelligence 4Market Research info@datamintelligence.com

  8. Nuclear Medicine Therapeutics Market|2022-2029 Some of the Major Players Covered in the Market: Some of the prominent companies contributing to the expansion of the market • • • • • • Nordion, Inc Bracco Imaging S.P.A Jubilant Life Sciences Ltd NTP Radioisotopes SOC Ltd The Australian Nuclear Science and Technology Organization The institute for radio elements Copy Right: DataM Intelligence 4Market Research info@datamintelligence.com

  9. || About Us || DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world. We monitor and analyze the market by dissecting various market influencers, competitive intensity, innovations, trends, and emerging products. This aids us in providing a detailed scenario of the present and future of the market. Copy Right: DataM Intelligence 4Market Research info@datamintelligence.com

  10. || Contact Us || Contact Us: Sai Kiran DataM Intelligence 4Market Research LLP +1 877–441–4866 info@datamintelligence.com Follow Us on Copy Right: DataM Intelligence 4Market Research info@datamintelligence.com

More Related